New: Evolving the Heatmap: Dow Jones, Nasdaq 100, Russell 2000, and More

Learn More
Index- P/E- EPS (ttm)-0.01 Insider Own96.15% Shs Outstand494.49M Perf Week14.54%
Market Cap7.54B Forward P/E- EPS next Y- Insider Trans0.00% Shs Float19.01M Perf Month14.41%
Enterprise Value7.53B PEG- EPS next Q- Inst Own0.14% Short Float9.98% Perf Quarter-80.46%
Income-4.09M P/S- EPS this Y- Inst Trans226.63% Short Ratio1.73 Perf Half Y1733.26%
Sales0.00M P/B1122.61 EPS next Y- ROA-45.55% Short Interest1.90M Perf YTD11626.92%
Book/sh0.01 P/C947.05 EPS next 5Y- ROE-48.45% 52W High83.60 -81.76% Perf Year10627.96%
Cash/sh0.02 P/FCF- EPS past 3/5Y-45.92% -61.17% ROIC-60.89% 52W Low0.09 16329.67% Perf 3Y2254.92%
Dividend Est.- EV/EBITDA- Sales past 3/5Y- - Gross Margin- Volatility5.86% 7.42% Perf 5Y-
Dividend TTM- EV/Sales- EPS Y/Y TTM12.63% Oper. Margin- ATR (14)1.22 Perf 10Y-
Dividend Ex-Date- Quick Ratio41.92 Sales Y/Y TTM- Profit Margin- RSI (14)56.99 Recom-
Dividend Gr. 3/5Y- - Current Ratio41.92 EPS Q/Q11.90% SMA2012.00% Beta2.09 Target Price-
Payout- Debt/Eq0.00 Sales Q/Q- SMA509.78% Rel Volume0.36 Prev Close14.31
Employees12 LT Debt/Eq0.00 Earnings- SMA20095.95% Avg Volume1.10M Price15.24
IPOJul 16, 2021 Option/ShortYes / No EPS/Sales Surpr.- - Trades Volume117,782 Change6.53%
Sep-04-25 01:01PM
Sep-03-25 03:51AM
Aug-04-25 03:51AM
Jul-31-25 11:31PM
Jul-17-25 03:51PM
02:26PM Loading…
Jul-08-25 02:26PM
Jul-07-25 10:34AM
Jul-01-25 03:51AM
Jun-30-25 04:03PM
Jun-27-25 12:05PM
05:18AM
Jun-20-25 03:06AM
Jun-17-25 12:43PM
12:25PM
Jun-16-25 04:30PM
11:00AM Loading…
11:00AM
Apr-30-25 06:01AM
Mar-22-25 11:00AM
Mar-21-25 06:35AM
Mar-17-25 07:28AM
Jul-23-24 04:02PM
Nov-15-23 04:31PM
Jul-31-23 08:15AM
Apr-03-23 07:25AM
Feb-21-23 06:36AM
Nov-21-22 06:49AM
Nov-15-22 07:55AM
Oct-25-22 06:55AM
Sep-14-22 06:55AM
Sep-12-22 09:15AM
05:27AM Loading…
Jun-20-22 05:27AM
May-24-22 05:46AM
May-18-22 08:05AM
06:14AM
May-16-22 08:56AM
Apr-14-22 10:03AM
Apr-07-22 06:09AM
Mar-01-22 08:30AM
Feb-17-22 11:40AM
Feb-16-22 08:42PM
Dec-13-21 08:35AM
Nov-22-21 08:15AM
08:00AM
Nov-02-21 04:00AM
Oct-19-21 11:44AM
Sep-10-21 06:18AM
02:42AM
Sep-02-21 08:00AM
Aug-20-21 08:00AM
Aug-05-21 08:00AM
Jul-20-21 04:05PM
Jul-16-21 11:43AM
Regencell Bioscience Holdings Ltd. engages in the research, development, and commercialization of traditional Chinese medicine. It seeks the treatment of neurocognitive disorders and degeneration, specifically attention deficit hyperactivity disorder and autism spectrum disorder. The company was founded by Yat-Gai Au on October 30, 2014 and is headquartered in Hong Kong.